• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞减灭性肾切除术治疗后的住院死亡率和未能抢救成功。

In-hospital mortality and failure to rescue after cytoreductive nephrectomy.

机构信息

Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.

出版信息

Eur Urol. 2013 Jun;63(6):1107-14. doi: 10.1016/j.eururo.2012.08.069. Epub 2012 Sep 7.

DOI:10.1016/j.eururo.2012.08.069
PMID:22981674
Abstract

BACKGROUND

The risk of in-hospital mortality after cytoreductive nephrectomy (CNT) is non-negligible and may vary widely according to various patient and hospital characteristics and clinical contexts.

OBJECTIVE

To better elucidate the mechanisms underlying variability in operative mortality after CNT.

DESIGN, SETTING, AND PATIENTS: Using the US-based Nationwide Inpatient Sample registry, a weighted estimate of 16 285 patients with metastatic renal cell carcinoma (mRCC) treated with CNT between 1998 and 2007 was made retrospectively.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

Failure to rescue (FTR), defined as the number of deaths in patients who developed an adverse outcome during hospitalization. Univariable and multivariable logistic regression models were used.

RESULTS

Of all 16 285 mRCC patients who underwent a CNT, 31% had an occurrence of one complication or more. The overall FTR rate was 5% and differed significantly according to age (≥ 75 yr vs <75 yr: 7.9% vs 4.3%) and comorbidities (≥ 3 vs 0: 7.7% vs 4.8%), as well as hospital bed size (small vs large: 7.2% vs 5.3%, all p ≤ 0.03). Patients who had an occurrence of infections (19.3%), cardiac- (15.7%), respiratory- (11.4%), or vascular-related complications (16.5%) had significantly higher FTR rates. It is noteworthy that increasing hospital volume and number of hospital beds also corresponded to lower rates of FTR after adjusting for other covariates.

CONCLUSIONS

Following CNT for mRCC, the occurrence of infections, cardiac-, respiratory-, or vascular-related complications resulted in higher FTR rates. Hospitals with greater number of beds and higher annual hospital volume had lower FTR rates, confirming the concepts that support FTR as an indicator for better quality of care following a high-risk surgical procedure.

摘要

背景

细胞减灭性肾切除术(CNT)后的住院死亡率不容忽视,且可能因患者和医院的各种特征以及临床情况而有很大差异。

目的

更好地阐明 CNT 术后手术死亡率差异的机制。

设计、设置和患者:使用基于美国的全国住院患者样本登记处,对 1998 年至 2007 年间接受 CNT 治疗的 16285 例转移性肾细胞癌(mRCC)患者进行了回顾性加权估计。

观察指标和统计分析

失败抢救(FTR)定义为在住院期间发生不良结局的患者的死亡人数。使用单变量和多变量逻辑回归模型。

结果

在所有接受 CNT 的 16285 例 mRCC 患者中,31%发生了 1 种或多种并发症。总体 FTR 率为 5%,且根据年龄(≥75 岁与<75 岁:7.9%与 4.3%)和合并症(≥3 种与 0 种:7.7%与 4.8%)以及医院床位数(小与大:7.2%与 5.3%,所有 p≤0.03)差异有统计学意义。发生感染(19.3%)、心脏(15.7%)、呼吸(11.4%)或血管相关并发症(16.5%)的患者 FTR 率显著更高。值得注意的是,在调整了其他协变量后,医院容量和床位数的增加也与 FTR 降低相关。

结论

在 mRCC 接受 CNT 后,发生感染、心脏、呼吸或血管相关并发症会导致更高的 FTR 率。床位数量更多和年住院量更高的医院 FTR 率更低,证实了 FTR 作为高风险手术术后更好护理质量的指标的概念。

相似文献

1
In-hospital mortality and failure to rescue after cytoreductive nephrectomy.细胞减灭性肾切除术治疗后的住院死亡率和未能抢救成功。
Eur Urol. 2013 Jun;63(6):1107-14. doi: 10.1016/j.eururo.2012.08.069. Epub 2012 Sep 7.
2
Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.细胞减灭性肾切除术治疗转移性肾细胞癌的死亡率和发病率:一项基于人群的研究。
Ann Surg Oncol. 2011 Oct;18(10):2988-96. doi: 10.1245/s10434-011-1715-2. Epub 2011 Apr 16.
3
Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.终末期肾病患者行肾切除术治疗非转移性肾癌的围手术期发病率和住院死亡率更高:一项基于人群的分析。
BJU Int. 2012 Sep;110(6 Pt B):E183-90. doi: 10.1111/j.1464-410X.2012.10936.x. Epub 2012 Feb 9.
4
Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA.老年人群行细胞减灭性肾切除术:来自美国的一项基于人群的队列研究。
BJU Int. 2012 Jun;109(12):1807-12. doi: 10.1111/j.1464-410X.2011.10569.x. Epub 2011 Sep 27.
5
The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer.肾细胞癌患者术后并发症与住院结局和费用的关系。
BJU Int. 2013 Apr;111(4):580-8. doi: 10.1111/j.1464-410X.2012.11122.x. Epub 2012 May 7.
6
Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series.开放性与腹腔镜肾部分切除术的并发症、输血、住院时间和院内死亡率的倾向评分匹配比较:一项全国性系列研究。
Eur J Surg Oncol. 2012 Jan;38(1):80-7. doi: 10.1016/j.ejso.2011.09.035. Epub 2011 Oct 13.
7
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients.老年患者减瘤性肾切除术后的并发症发生率、抢救失败率及住院死亡率。
J Geriatr Oncol. 2020 May;11(4):718-723. doi: 10.1016/j.jgo.2019.06.005. Epub 2019 Jun 27.
8
Failure to rescue in safety-net hospitals: availability of hospital resources and differences in performance.安全网医院的救援失败:医院资源的可用性和绩效差异。
JAMA Surg. 2014 Mar;149(3):229-35. doi: 10.1001/jamasurg.2013.3566.
9
In-hospital mortality and failure-to-rescue rates after radical cystectomy.根治性膀胱切除术的住院死亡率和救援失败率。
BJU Int. 2013 Jul;112(2):E20-7. doi: 10.1111/bju.12214.
10
Cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based analysis of perioperative outcomes according to clinical stage.转移性肾细胞癌的减瘤性肾切除术:基于人群的围手术期结局按临床分期分析
Int J Urol. 2014 Aug;21(8):770-5. doi: 10.1111/iju.12446. Epub 2014 Apr 8.

引用本文的文献

1
Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: Is There Still a Debate?减瘤性肾切除术在转移性肾细胞癌治疗中的应用:仍存在争议吗?
Curr Urol Rep. 2021 Oct 16;22(11):54. doi: 10.1007/s11934-021-01073-7.
2
The role of open radical nephrectomy in contemporary management of renal cell carcinoma.开放性根治性肾切除术在当代肾细胞癌治疗中的作用。
Transl Androl Urol. 2020 Dec;9(6):3123-3139. doi: 10.21037/tau-19-327.
3
Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma.重新定义转移性肾细胞癌的外科治疗角色。
Curr Oncol Rep. 2020 Mar 13;22(4):35. doi: 10.1007/s11912-020-0895-y.
4
Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis.转移性肾细胞癌患者的治疗设施容量与生存:基于登记的分析。
Eur Urol. 2018 Sep;74(3):387-393. doi: 10.1016/j.eururo.2018.05.025. Epub 2018 Jun 5.
5
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review.靶向治疗时代转移性肾细胞癌患者的细胞减灭性肾切除术:文献复习。
World J Urol. 2017 Dec;35(12):1807-1816. doi: 10.1007/s00345-017-2072-y. Epub 2017 Jul 12.
6
Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.晚期和转移性肾细胞癌的外科治疗:多学科方法
Front Oncol. 2017 May 31;7:107. doi: 10.3389/fonc.2017.00107. eCollection 2017.
7
Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA.术前变量的验证及患者分层,以帮助预测在靶向治疗时代减瘤性肾切除术的获益情况。
Int Braz J Urol. 2017 May-Jun;43(3):432-439. doi: 10.1590/S1677-5538.IBJU.2015.0118.
8
Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study.接受或未接受减瘤性肾切除术的靶向治疗的转移性肾癌患者的生存分析:一项国家癌症数据库研究
J Clin Oncol. 2016 Sep 20;34(27):3267-75. doi: 10.1200/JCO.2016.66.7931. Epub 2016 Jun 20.
9
Current Status of Minimally Invasive Surgery for Renal Cell Carcinoma.肾细胞癌微创手术的现状
Curr Urol Rep. 2016 Jun;17(6):43. doi: 10.1007/s11934-016-0599-x.
10
Trends and variations in the rates of hospital complications, failure-to-rescue and 30-day mortality in surgical patients in New South Wales, Australia, 2002-2009.2002年至2009年澳大利亚新南威尔士州外科手术患者的医院并发症发生率、未能成功抢救率及30天死亡率的趋势与变化
PLoS One. 2014 May 1;9(5):e96164. doi: 10.1371/journal.pone.0096164. eCollection 2014.